$33M sweet spot round size
Most of their 7 investments are in rounds between $16M and $35M
1997
Alto Neuroscience raised $35M on October 25, 2022
Investors: Valor Equity Partners, infinitas capital, Vine Ventures, L.P., Presight Capital, Windham Venture Partners, Korify Capital AG, The Sobrato Organization and Novartis Japan
H1 raised $23M on June 9, 2022
Investors: Goldman Sachs Asset Management, Menlo Ventures, Leerink Transformation Partners and Novartis Japan
SomaLogic raised $375M on September 1, 2021
Investors: Casdin Capital, LLC, T. Rowe Price, Corvex Connected Worker™, Perceptive Advisors, Farallon Capital Management and Novartis Japan
Dopavision raised $14M on July 14, 2021
Investors: Ababax.Health, dRx data and Novartis Japan
Vineti raised $33M on October 13, 2020
Investors: Casdin Capital, LLC, Section 32, Lifeforce Capital, Canaan, Threshold Ventures and Novartis Japan
Koneksa raised $16M on September 28, 2020
Investors: dRx data, Spring Mountain Capital, MBX Capital, Waterline Ventures and Novartis Japan
Vineti raised $35M on February 5, 2020
Investors: Threshold Ventures, Casdin Capital, LLC, Section 32, -, Lifeforce Capital, Gilead Sciences, dRx data and Novartis Japan